4//SEC Filing
Liu David R. 4
Accession 0001628280-22-027123
CIK 0001894562other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 8:00 PM ET
Size
6.9 KB
Accession
0001628280-22-027123
Insider Transaction Report
Form 4
Liu David R.
10% Owner
Transactions
- Conversion
Common Stock
2022-10-24+321,665→ 21,156,945 total - Conversion
Series A Convertible Preferred Stock
2022-10-24−1,000,001→ 0 total→ Common Stock (321,665 underlying)
Footnotes (1)
- [F1]The shares of Series A Convertible Preferred Stock (the "Series A Preferred Stock") were convertible into Common Stock on a one-for-3.10880 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on October 24, 2022. The Series A Preferred Stock had no expiration date.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001664439
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 8:00 PM ET
- Size
- 6.9 KB